Our news library that includes all press releases and industry related news.
In the news February 28, 2023
This article originally appeared in Maclean’s print and healthinsights.ca on February 16, 2023 Canada desperately needs a rare disease strategy that’ll enable […]
In the news January 25, 2023
This article originally appeared in Research Money on January 25, 2023. A dwindling workforce, inefficient regulations, and lack of much-needed […]
In the news January 13, 2023
We need to work together to evolve the private market so that it continues to have the value of providing […]
In the news December 20, 2022
Pamela Fralick, President, Innovative Medicines Canada This article originally appeared in National Newswatch on December 20, 2022. In 2019, the […]
In the news December 15, 2022
Pamela Fralick, President, Innovative Medicines Canada *This article originally appeared in the Toronto Star on December 15, 2022. In 2016, […]
Featured News November 21, 2022
This article originally appeared in The Toronto Star on November 21, 2022. Microbes can change over time, developing resistance against […]
In the news November 14, 2022
This article originally appeared on The Globe and Mail on November 14, 2022. Despite ongoing challenges that have been made […]
In the news November 02, 2022
Some members of the pharmaceutical industry have argued throughout the COVID-19 pandemic that intellectual property is not the primary cause […]
In the news October 26, 2022
This article originally appeared on HRI Portal on October 26, 2022. Every day, life sciences researchers work tirelessly to improve […]
In the news October 03, 2022
AMR is rendering the global antibiotic arsenal ineffective. Left unchecked, it will lead to the collapse of Canadian health systems. […]
In the news August 12, 2022
This article was originally posted on Benefits Canada on August 12, 2021. There’s no question that Canadians value their private […]
In the news June 30, 2022
This article originally appeared on Benefits Canada on June 30, 2022. The amendments to the Patented Medicine Prices Review Board […]
Informative content to keep you up to date on the most pressing issues facing our industry.
